JAL Medical Singapore’s goal is to serve our global partners with a truly integrated biomedical manufacturing facility by offering a wide range of advanced rapid in-vitro immunodiagnostic test systems and electrical bio sensing systems, particularly blood glucose monitoring systems for home and professional use. As a leading manufacturer and distributor, We are committed to serve our partners by manufacturing and distributing high quality, reliable and competitive products and services to every continent. Our vision is to provide safe, reliable and cost effective solutions in markets around the world.
We are pleased to announce that JAL Group of Companies (JAL Medical Singapore & JAL Innovation Singapore) in close tandem with our South Africa partner Armada Diagnostics Pty Ltd have successfully won the South African National Dept of Health continually for 9 years in a row from 2014 to 2023.
We are supplying our co-branded WHO pre-qualified HIV 1&2 diagnostic test kits. Once again, through a unified collaborative effort, we are exceptionally pleased to announce our compelling success in winning the 3rd consecutive tenders.
These tenders were reputed to be the largest supply of diagnostic test kits tender in the world. During these years, more than 65 million diagnostic test kits were delivered and used successfully. During THE years 2020 to 2023 new allotment, we are expected to deliver another 42 million diagnostic test kits.
In addition, JAL Medical Singapore commands good market share for our iCare Advanced blood glucose monitoring systems in Laos, Cote d’Ivorie, Nigeria to name a few. Our rapid diagnostic test kits are supplied to key projects in Myanmar, Laos, New Zealand, Equatorial New Guinea, Thailand as well as in several Pacific and Caribbean Islands.
Our strong team work, our global brand, consistent product quality and good support services have contributed to our global success.
We take this opportunity to thank all our global partners for contributing to our growth for the past 18 years.